ATAI logo

Atai Life Sciences NV (ATAI) EBITDA

Annual EBITDA

-$36.31 M
+$97.78 M+72.92%

December 31, 2023

Summary

Performance

1-Year Change

+72.92%

3-Year Change

+60.58%

5-Year Change

-340.76%

15-Year Change

-394.8%

ATAI EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.86%
ATAI annual EBITDA is higher than 38.86% of companies in Healthcare sector

High & Low

All-time High

$11.83 M
ATAI annual EBITDA is currently -406.83% below its historical high of $11.83 million

3-Year Low

-$134.09 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ATAI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 15, 2025
ATAI next annual earnings announcement is scheduled for May 15, 2025

OtherATAIprofitabilitymetrics:

Annual Revenue

$314.00 K
ATAI annual revenue is $314.00 thousand

Annual Net Income

-$40.22 M
ATAI annual net profit is -$40.22 million

Annual EBIT

-$36.63 M
ATAI annual earnings before interest & taxes is -$36.63 million

Annual EPS

-$0.25
ATAI annual earnings per share is -$0.25

Quarterly EBITDA

-$25.60 M
+$30.70 M+54.53%

September 30, 2024

Summary

Performance

3-Month Change

+54.53%

1-Year Change

-157.38%

3-Year Change

+19.66%

5-Year Change

+19.66%

ATAI Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.97%
ATAI quarterly EBITDA is higher than 17.97% of companies in Healthcare sector

High & Low

All-time High

$44.61 M
ATAI quarterly EBITDA is currently -157.38% below its historical high of $44.61 million

3-Year Low

-$56.29 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ATAI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
ATAI next earnings announcement is scheduled for May 15, 2025

OtherATAIprofitabilitymetrics:

Quarterly Revenue

$40.00 K
ATAI quarterly revenue is $40.00 thousand

Quarterly Net Income

-$26.29 M
ATAI quarterly net profit is -$26.29 million

Quarterly EBIT

-$25.68 M
ATAI quarterly earnings before interest & taxes is -$25.68 million

Quarterly EPS

-$0.16
ATAI quarterly earnings per share is -$0.16

TTM EBITDA

-$124.33 M
-$70.20 M-129.71%

September 30, 2024

Summary

Performance

3-Month Change

-129.71%

1-Year Change

-117.63%

3-Year Change

+20.89%

5-Year Change

+20.89%

ATAI TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

14.32%
ATAI TTM EBITDA is higher than 14.32% of companies in Healthcare sector

High & Low

All-time High

$12.17 M
ATAI TTM EBITDA is currently -1121.52% below its historical high of $12.17 million

3-Year Low

-$157.16 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ATAI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
ATAI next earnings announcement is scheduled for May 15, 2025

OtherATAIprofitabilitymetrics:

TTM Revenue

$331.00 K
ATAI TTM revenue is $331.00 thousand

TTM Net Income

-$128.60 M
ATAI TTM net profit is -$128.60 million

TTM EBIT

-$124.68 M
ATAI TTM earnings before interest & taxes is -$124.68 million

TTM EPS

-$0.80
ATAI TTM earnings per share is -$0.80

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$36.31 M
ATAI annual EBITDA is -$36.31 million

Annual Net Income

-$40.22 M
ATAI annual net profit is -$40.22 million

Annual Interest Expense

$2.66 M
ATAI annual interest expense is $2.66 million

Annual Income Tax

$1.02 M
ATAI annual income tax is $1.02 million

Annual D&A

$319.00 K
ATAI annual depreciation & amortization is $319.00 thousand

ATAI EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+72.9%-157.4%-117.6%
3 y3 years+60.6%+19.7%+20.9%
5 y5 years-340.8%+19.7%+20.9%

ATAI EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+72.9%-157.4%+54.5%-332.4%+20.9%
5 y5-year-344.6%+72.9%-157.4%+66.0%-694.2%+20.9%
alltimeall time-406.8%+72.9%-157.4%+66.0%-1121.5%+20.9%

Atai Life Sciences NV EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$25.60 M(-54.5%)
-$124.33 M(+129.7%)
Jun 2024
-
-$56.29 M(+126.0%)
-$54.13 M(+88.2%)
Mar 2024
-
-$24.91 M(+42.1%)
-$28.75 M(-20.8%)
Dec 2023
-$36.31 M(-72.9%)
-$17.53 M(-139.3%)
-$36.31 M(-36.4%)
Sep 2023
-
$44.61 M(-244.3%)
-$57.13 M(-57.6%)
Jun 2023
-
-$30.92 M(-4.8%)
-$134.83 M(+0.1%)
Mar 2023
-
-$32.47 M(-15.3%)
-$134.70 M(+0.5%)
Dec 2022
-$134.09 M(+11.5%)
-$38.34 M(+15.9%)
-$134.09 M(-0.2%)
Sep 2022
-
-$33.10 M(+7.5%)
-$134.35 M(-0.2%)
Jun 2022
-
-$30.79 M(-3.4%)
-$134.61 M(-14.3%)
Mar 2022
-
-$31.86 M(-17.5%)
-$157.16 M(+30.7%)
Dec 2021
-$120.28 M(+30.6%)
-$38.60 M(+15.7%)
-$120.27 M(-23.4%)
Sep 2021
-
-$33.36 M(-37.5%)
-$156.99 M(+19.8%)
Jun 2021
-
-$53.34 M(-1160.8%)
-$131.01 M(+57.1%)
Mar 2021
-
$5.03 M(-106.7%)
-$83.38 M(-9.5%)
Dec 2020
-$92.12 M(+1027.8%)
-$75.32 M(+920.5%)
-$92.12 M(+292.3%)
Sep 2020
-
-$7.38 M(+29.4%)
-$23.48 M(+18.4%)
Jun 2020
-
-$5.70 M(+53.6%)
-$19.83 M(+16.1%)
Mar 2020
-
-$3.71 M(-44.5%)
-$17.08 M(+9.1%)
Dec 2019
-$8.17 M(-0.9%)
-
-
Dec 2019
-
-$6.69 M(+79.4%)
-$15.65 M(+30.7%)
Sep 2019
-
-$3.73 M(+26.1%)
-$11.98 M(+21.5%)
Jun 2019
-
-$2.95 M(+29.2%)
-$9.86 M(-3.2%)
Mar 2019
-
-$2.29 M(-24.1%)
-$10.18 M(-1.2%)
Dec 2018
-$8.24 M(+12.3%)
-$3.01 M(+87.9%)
-$10.31 M(+41.3%)
Sep 2018
-
-$1.60 M(-51.1%)
-$7.30 M(-10.9%)
Jun 2018
-
-$3.28 M(+35.9%)
-$8.20 M(+43.9%)
Mar 2018
-
-$2.41 M(-3.4%)
-$5.70 M(-26.0%)
Dec 2017
-$7.34 M(+6.4%)
-
-
Sep 2017
-
-$2.50 M(+219.7%)
-$7.69 M(+16.7%)
Jun 2017
-
-$781.90 K(-95.6%)
-$6.59 M(+61.1%)
Mar 2017
-$6.90 M(-172.7%)
-$17.82 M(-232.9%)
-$4.09 M(-133.6%)
Dec 2016
-
$13.40 M(-1059.2%)
$12.17 M(+29.7%)
Sep 2016
-
-$1.40 M(-181.4%)
$9.38 M(+6.1%)
Jun 2016
-
$1.72 M(-210.5%)
$8.84 M(+3.5%)
Mar 2016
$9.49 M(+56.5%)
-$1.55 M(-114.6%)
$8.54 M(+17.3%)
Dec 2015
-
$10.62 M(-648.2%)
$7.28 M(+353.7%)
Sep 2015
-
-$1.94 M(-236.6%)
$1.61 M(-68.2%)
Jun 2015
-
$1.42 M(-150.4%)
$5.05 M(+3.2%)
DateAnnualQuarterlyTTM
Mar 2015
$6.06 M(-42.2%)
-$2.81 M(-157.0%)
$4.89 M(-32.6%)
Dec 2014
-
$4.94 M(+227.2%)
$7.26 M(-32.8%)
Sep 2014
-
$1.51 M(+19.7%)
$10.80 M(+26.6%)
Jun 2014
-
$1.26 M(-380.1%)
$8.53 M(-2.5%)
Mar 2014
$10.48 M(+75.4%)
-$450.30 K(-105.3%)
$8.75 M(+9.3%)
Dec 2013
-
$8.48 M(-1212.9%)
$8.01 M(+36.6%)
Sep 2013
-
-$762.30 K(-151.4%)
$5.87 M(+19.8%)
Jun 2013
-
$1.48 M(-224.4%)
$4.90 M(+13.0%)
Mar 2013
$5.98 M(-49.5%)
-$1.19 M(-118.8%)
$4.33 M(-29.9%)
Dec 2012
-
$6.34 M(-465.9%)
$6.18 M(-8.5%)
Sep 2012
-
-$1.73 M(-288.7%)
$6.76 M(-23.4%)
Jun 2012
-
$917.80 K(+40.2%)
$8.83 M(-12.5%)
Mar 2012
$11.83 M(+130.5%)
$654.50 K(-90.5%)
$10.08 M(+22.9%)
Dec 2011
-
$6.92 M(+1950.3%)
$8.20 M(+26.4%)
Sep 2011
-
$337.30 K(-84.5%)
$6.49 M(+77.3%)
Jun 2011
-
$2.18 M(-277.6%)
$3.66 M(+17.3%)
Mar 2011
$5.13 M(-302.5%)
-$1.23 M(-123.6%)
$3.12 M(-356.3%)
Dec 2010
-
$5.20 M(-308.8%)
-$1.22 M(-75.6%)
Sep 2010
-
-$2.49 M(-252.3%)
-$5.00 M(-0.7%)
Jun 2010
-
$1.64 M(-129.4%)
-$5.03 M(+14.5%)
Mar 2010
-$2.54 M(-155.0%)
-$5.56 M(-491.3%)
-$4.39 M(+500.4%)
Dec 2009
-
$1.42 M(-156.3%)
-$731.50 K(+177.0%)
Sep 2009
-
-$2.52 M(-211.0%)
-$264.10 K(-107.4%)
Jun 2009
-
$2.27 M(-219.5%)
$3.54 M(-7.2%)
Mar 2009
$4.61 M(+31.2%)
-$1.90 M(-200.7%)
$3.82 M(-20.4%)
Dec 2008
-
$1.89 M(+47.1%)
$4.80 M(-17.4%)
Sep 2008
-
$1.28 M(-49.6%)
$5.81 M(+13.8%)
Jun 2008
-
$2.55 M(-376.2%)
$5.10 M(-32.9%)
Mar 2008
$3.51 M(-265.3%)
-$922.70 K(-131.8%)
$7.60 M(-648.2%)
Dec 2007
-
$2.90 M(+400.8%)
-$1.39 M(+46.1%)
Sep 2007
-
$579.00 K(-88.5%)
-$949.10 K(-285.7%)
Jun 2007
-
$5.05 M(-150.9%)
$511.00 K(-120.3%)
Mar 2007
-$2.12 M(+1567.9%)
-$9.91 M(-397.0%)
-$2.51 M(-134.0%)
Dec 2006
-
$3.34 M(+63.7%)
$7.40 M(+82.2%)
Sep 2006
-
$2.04 M(+0.8%)
$4.06 M(+100.8%)
Jun 2006
-
$2.02 M
$2.02 M
Mar 2006
-$127.30 K(-102.4%)
-
-
Mar 2004
$5.38 M(+96.9%)
-
-
Dec 2003
$2.73 M
-
-

FAQ

  • What is Atai Life Sciences NV annual EBITDA?
  • What is the all time high annual EBITDA for Atai Life Sciences NV?
  • What is Atai Life Sciences NV annual EBITDA year-on-year change?
  • What is Atai Life Sciences NV quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Atai Life Sciences NV?
  • What is Atai Life Sciences NV quarterly EBITDA year-on-year change?
  • What is Atai Life Sciences NV TTM EBITDA?
  • What is the all time high TTM EBITDA for Atai Life Sciences NV?
  • What is Atai Life Sciences NV TTM EBITDA year-on-year change?

What is Atai Life Sciences NV annual EBITDA?

The current annual EBITDA of ATAI is -$36.31 M

What is the all time high annual EBITDA for Atai Life Sciences NV?

Atai Life Sciences NV all-time high annual EBITDA is $11.83 M

What is Atai Life Sciences NV annual EBITDA year-on-year change?

Over the past year, ATAI annual EBITDA has changed by +$97.78 M (+72.92%)

What is Atai Life Sciences NV quarterly EBITDA?

The current quarterly EBITDA of ATAI is -$25.60 M

What is the all time high quarterly EBITDA for Atai Life Sciences NV?

Atai Life Sciences NV all-time high quarterly EBITDA is $44.61 M

What is Atai Life Sciences NV quarterly EBITDA year-on-year change?

Over the past year, ATAI quarterly EBITDA has changed by -$70.20 M (-157.38%)

What is Atai Life Sciences NV TTM EBITDA?

The current TTM EBITDA of ATAI is -$124.33 M

What is the all time high TTM EBITDA for Atai Life Sciences NV?

Atai Life Sciences NV all-time high TTM EBITDA is $12.17 M

What is Atai Life Sciences NV TTM EBITDA year-on-year change?

Over the past year, ATAI TTM EBITDA has changed by -$67.20 M (-117.63%)